PT-141 (Bremelanotide) 10 mg by Hilma Biocare is a specialized, synthetic peptide derived from the melanotan-2 sequence, designed without the tanning-inducing properties of its predecessor. As a non-selective melanocortin receptor agonist, PT-141 acts directly on the central nervous system to study arousal pathways and desire mechanisms. It is widely utilized in advanced scientific research focusing on sexual dysfunction and neurological responses.

• Active Substance: Bremelanotide (PT-141) 10 mg / vial

• Manufacturer: Hilma Biocare

• Form: Lyophilized Research Peptide Vial

• Quality Standard: HPLC Tested / Pharmaceutical Grade

Key Benefits:

• Central Nervous System Action: Acts directly via the brain's melanocortin receptors rather than through the vascular system.

• High Purity & Stability: Manufactured under strict pharmaceutical standards with verified HPLC purity.

• Targeted Research Compound: Widely studied for pathways related to intimate health and neurological signaling.

Frequently Asked Questions (FAQ)

• Q: How is PT-141 typically reconstituted for research?

  A: It is reconstituted using a precise amount of bacteriostatic water and stored in refrigerated conditions (2–8°C) to maintain stability.

• Q: How does PT-141 differ from standard erectile dysfunction treatments?

  A: Unlike PDE5 inhibitors that affect blood flow locally, PT-141 operates centrally through the brain's nervous system to stimulate arousal pathways.

• Q: Does PT-141 cause skin tanning like Melanotan II?

  A: No, PT-141 lacks the specific structural components that cause significant melanogenesis (skin darkening), making it distinct from MT-2.